|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquired
|
Nucletron
|
|
gptkbp:annual_report
|
Available online
|
|
gptkbp:awards
|
gptkb:Red_Dot_Design_Award
|
|
gptkbp:ceo
|
Gustav Emilsson
|
|
gptkbp:competitors
|
gptkb:Siemens_Healthineers
gptkb:Philips_Healthcare
gptkb:Varian_Medical_Systems
Accuray
|
|
gptkbp:employees
|
~4,000
|
|
gptkbp:focus
|
gptkb:Oncology
Neurosurgery
Radiotherapy
Stereotactic Surgery
|
|
gptkbp:founded_in
|
gptkb:1972
|
|
gptkbp:global_presence
|
Over 120 countries
|
|
gptkbp:headquarters
|
gptkb:Stockholm,_Sweden
|
|
gptkbp:history
|
Expanded internationally in the 1990s
Acquired several companies to enhance portfolio
Developed the first commercial Gamma Knife in 1968
Founded by Lars Leksell
Listed on the stock exchange in 1983
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Elekta Gmb H
|
|
gptkbp:industry
|
gptkb:health_services
|
|
gptkbp:innovation
|
Continuous product development
Collaboration with research institutions
Investment in new technologies
Focus on patient-centered solutions
Integration of AI in healthcare solutions
|
|
gptkbp:investment
|
gptkb:public_company
|
|
gptkbp:operates_in
|
Global Market
|
|
gptkbp:partnerships
|
Various hospitals and clinics
|
|
gptkbp:products
|
gptkb:Leksell_Gamma_Knife
gptkb:Elekta_Unity
gptkb:Elekta_Versa
|
|
gptkbp:research_and_development
|
Significant investment
|
|
gptkbp:revenue
|
€1.1 billion (2020)
|
|
gptkbp:specializes_in
|
Radiation Therapy
|
|
gptkbp:stock_exchange
|
gptkb:Nasdaq_Stockholm
|
|
gptkbp:stock_symbol
|
EKTAB
|
|
gptkbp:subsidiaries
|
gptkb:Elekta_Inc.
gptkb:Elekta_Limited
gptkb:Elekta_S._A.
gptkb:Elekta_AB
|
|
gptkbp:sustainability
|
Community engagement programs
Ethical business practices
Corporate social responsibility initiatives
Employee welfare programs
Focus on environmental impact
|
|
gptkbp:trademark
|
gptkb:Gamma_Knife
gptkb:Eldrazi
gptkb:Elekta_Unity
gptkb:Elekta_Versa
Leksell
|
|
gptkbp:website
|
www.elekta.com
|
|
gptkbp:bfsParent
|
gptkb:Eldrazi
|
|
gptkbp:bfsLayer
|
5
|